CoChat

Modification-free approaches to screen drug targets at proteome level

Lyu, Jiawen, Wang, Keyun, Ye, Mingliang · 2020 · TrAC Trends in Analytical Chemistry
Cited by 42

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.trac.2019.06.024

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 90

  1. Lounkine, 2012, Large-scale prediction and testing of drug activity on side-effect targets, Nature, 486, 361, 10.1038/nature11159 · DOI · Paper page
  2. Schenone, 2013, Target identification and mechanism of action in chemical biology and drug discovery, Nat. Chem. Biol., 9, 232, 10.1038/nchembio.1199 · DOI · Paper page
  3. Overington, 2006, How many drug targets are there?, Nat. Rev. Drug Discov., 5, 993, 10.1038/nrd2199 · DOI · Paper page
  4. Ramsay, 2018, A perspective on multi-target drug discovery and design for complex diseases, Clin. Transl. Med., 7, 3, 10.1186/s40169-017-0181-2 · DOI · Paper page
  5. Giaever, 2004, Chemogenomic profiling: identifying the functional interactions of small molecules in yeast, Proc. Natl. Acad. Sci. U. S. A., 101, 793, 10.1073/pnas.0307490100 · DOI · Paper page
  6. Hoon, 2008, An integrated platform of genomic assays reveals small-molecule bioactivities, Nat. Chem. Biol., 4, 498, 10.1038/nchembio.100 · DOI · Paper page
  7. Parsons, 2006, Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast, Cell, 126, 611, 10.1016/j.cell.2006.06.040 · DOI · Paper page
  8. Mulder, 2018, Proteomic tools to study drug function, Curr. Opin. Struct. Biol., 10, 9
  9. Uzozie, 2018, Advancing translational research and precision medicine with targeted proteomics, J. Proteom., 189, 1, 10.1016/j.jprot.2018.02.021 · DOI
  10. Sleno, 2008, Proteomic methods for drug target discovery, Curr. Opin. Chem. Biol., 12, 46, 10.1016/j.cbpa.2008.01.022 · DOI
  11. Bantscheff, 2009, Revealing promiscuous drug-target interactions by chemical proteomics, Drug Discov. Today, 14, 1021, 10.1016/j.drudis.2009.07.001 · DOI
  12. Rix, 2009, Target profiling of small molecules by chemical proteomics, Nat. Chem. Biol., 5, 616, 10.1038/nchembio.216 · DOI · Paper page
  13. Bantscheff, 2007, Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors, Nat. Biotechnol., 25, 1035, 10.1038/nbt1328 · DOI · Paper page
  14. Rix, 2007, Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets, Blood, 110, 4055, 10.1182/blood-2007-07-102061 · DOI · Paper page
  15. Speers, 2004, Chemical strategies for activity-based proteomics, Chembiochem, 5, 41, 10.1002/cbic.200300721 · DOI · Paper page
  16. Jessani, 2004, The development and application of methods for activity-based protein profiling, Curr. Opin. Chem. Biol., 8, 54, 10.1016/j.cbpa.2003.11.004 · DOI · Paper page
  17. Barglow, 2007, Activity-based protein profiling for the functional annotation of enzymes, Nat. Methods, 4, 822, 10.1038/nmeth1092 · DOI · Paper page
  18. Frei, 2012, Direct identification of ligand-receptor interactions on living cells and tissues, Nat. Biotechnol., 30, 997, 10.1038/nbt.2354 · DOI · Paper page
  19. Schirle, 2016, Identifying compound efficacy targets in phenotypic drug discovery, Drug Discov. Today, 21, 82, 10.1016/j.drudis.2015.08.001 · DOI · Paper page
  20. Lee, 2013, Target deconvolution techniques in modern phenotypic profiling, Curr. Opin. Chem. Biol., 17, 118, 10.1016/j.cbpa.2012.12.022 · DOI
  21. Cardoza, 2012, Mass spectrometry-based proteomics: qualitative identification to activity-based protein profiling, Wiley Interdiscip. Rev. Syst. Biol. Med., 4, 141, 10.1002/wsbm.166 · DOI
  22. Saxena, 2009, Small-molecule affinity chromatography coupled mass spectrometry for drug target deconvolution, Expert Opin. Drug Discov., 4, 701, 10.1517/17460440903005565 · DOI
  23. Rylova, 2015, Affinity-based methods in drug-target discovery, Curr. Drug Targets, 16, 60, 10.2174/1389450115666141120110323 · doi:10.2174/1389450115666141120110323
  24. Chang, 2016, Advances in identification and validation of protein targets of natural products without chemical modification, Nat. Prod. Rep., 33, 719, 10.1039/C5NP00107B · DOI
  25. Shiyama, 2004, Design and synthesis of novel hydrophilic spacers for the reduction of nonspecific binding proteins on affinity resins, Bioorg. Med. Chem., 12, 2831, 10.1016/j.bmc.2004.03.052 · DOI
  26. Scholten, 2006, Analysis of the cGMP/cAMP interactome using a chemical proteomics approach in mammalian heart tissue validates sphingosine kinase type 1-interacting protein as a genuine and highly abundant AKAP, J. Proteome Res., 5, 1435, 10.1021/pr0600529 · DOI
  27. Boersema, 2015, Proteomics beyond large-scale protein expression analysis, Curr. Opin. Biotechnol., 34, 162, 10.1016/j.copbio.2015.01.005 · DOI
  28. Ma, 2018, Overview of the detection methods for equilibrium dissociation constant KD of drug-receptor interaction, J. Pharm. Anal., 8, 147, 10.1016/j.jpha.2018.05.001 · DOI
  29. Brooks, 2001, J. Statistical thermodynamics. Taking a walk on a landscape, Science, 293, 612, 10.1126/science.1062559 · DOI · Paper page
  30. Gilli, 1994, Enthalpy-entropy compensation in drug-receptor binding, J. Phys. Chem., 98, 1515, 10.1021/j100056a024 · DOI · Paper page
  31. Liu, 2011, Energetics-based discovery of protein–ligand interactions on a proteomic scale, J. Mol. Biol., 408, 147, 10.1016/j.jmb.2011.02.026 · DOI
  32. Geer, 2014, Energetics-based methods for protein folding and stability measurements, Annu. Rev. Anal. Chem. (Palo Alto Calif), 7, 209, 10.1146/annurev-anchem-071213-020024 · DOI
  33. Park, 2007, Energetics-based protein profiling on a proteomic scale: identification of proteins resistant to proteolysis, J. Mol. Biol., 368, 1426, 10.1016/j.jmb.2007.02.091 · DOI
  34. Groftehauge, 2015, Protein-ligand interactions investigated by thermal shift assays (TSA) and dual polarization interferometry (DPI), Acta Crystallogr. D Biol. Crystallogr., 71, 36, 10.1107/S1399004714016617 · DOI
  35. Senisterra, 2006, Screening for ligands using a generic and high-throughput light-scattering-based assay, J. Biomol. Screen, 11, 940, 10.1177/1087057106294699 · DOI · Paper page
  36. Ericsson, 2006, Thermofluor-based high-throughput stability optimization of proteins for structural studies, Anal. Biochem., 357, 289, 10.1016/j.ab.2006.07.027 · DOI · Paper page
  37. Pantoliano, 2001, High-density miniaturized thermal shift assays as a general strategy for drug discovery, J. Biomol. Screen, 6, 429, 10.1177/108705710100600609 · DOI · Paper page
  38. Jafari, 2014, The cellular thermal shift assay for evaluating drug target interactions in cells, Nat. Protoc., 9, 2100, 10.1038/nprot.2014.138 · DOI · Paper page
  39. Almqvist, 2016, CETSA screening identifies known and novel thymidylate synthase inhibitors and slow intracellular activation of 5-fluorouracil, Nat. Commun., 7, 10.1038/ncomms11040 · DOI · Paper page
  40. Tan, 2015, Assessing the efficacy of Mdm2/Mdm4-inhibiting stapled peptides using cellular thermal shift assays, Sci. Rep., 5
  41. Xu, 2015, Discovery and characterization of novel small-molecule inhibitors targeting nicotinamide phosphoribosyltransferase, Sci. Rep., 5, 10043, 10.1038/srep10043 · DOI · Paper page
  42. Ishii, 2017, CETSA quantitatively verifies in vivo target engagement of novel RIPK1 inhibitors in various biospecimens, Sci. Rep., 7, 10.1038/s41598-017-12513-1 · DOI · Paper page
  43. Alshareef, 2016, The use of cellular thermal shift assay (CETSA) to study Crizotinib resistance in ALK-expressing human cancers, Sci. Rep., 6, 33710, 10.1038/srep33710 · DOI
  44. Mateus, 2017, Thermal proteome profiling: unbiased assessment of protein state through heat-induced stability changes, Proteome Sci., 15
  45. Franken, 2015, Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry, Nat. Protoc., 10, 1567, 10.1038/nprot.2015.101 · DOI · Paper page
  46. Azimi, 2018, Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors, Mol. Syst. Biol., 14, e7858, 10.15252/msb.20177858 · DOI
  47. Miettinen, 2018, Thermal proteome profiling of breast cancer cells reveals proteasomal activation by CDK4/6 inhibitor palbociclib, EMBO J., 37, e98359, 10.15252/embj.201798359 · DOI · Paper page
  48. Sridharan, 2019, Proteome-wide solubility and thermal stability profiling reveals distinct regulatory roles for ATP, Nat. Commun., 10, 1155, 10.1038/s41467-019-09107-y · DOI · Paper page
  49. Peng, 2016, An unbiased chemical proteomics method identifies FabI as the primary target of 6-OH-BDE-47, Environ. Sci. Technol., 50, 11329, 10.1021/acs.est.6b03541 · DOI · Paper page
  50. Hashimoto, 2018, Detection of chemical engagement of solute carrier proteins by a cellular thermal shift assay, ACS Chem. Biol., 13, 1480, 10.1021/acschembio.8b00270 · DOI
  51. Reinhard, 2015, Thermal proteome profiling monitors ligand interactions with cellular membrane proteins, Nat. Methods, 12, 1129, 10.1038/nmeth.3652 · DOI · Paper page
  52. Scheele, 2018, Toxoplasma calcium-dependent protein kinase 1 inhibitors: probing activity and resistance using cellular thermal shift assays, Antimicrob. Agents Chemother., 62, 10.1128/AAC.00051-18 · DOI
  53. West, 2008, Thermodynamic analysis of protein stability and ligand binding using a chemical modification- and mass spectrometry-based strategy, Anal. Chem., 80, 4175, 10.1021/ac702610a · DOI · Paper page
  54. Strickland, 2013, Thermodynamic analysis of protein-ligand binding interactions in complex biological mixtures using the stability of proteins from rates of oxidation, Nat. Protoc., 8, 148, 10.1038/nprot.2012.146 · DOI
  55. West, 2010, Quantitative proteomics approach for identifying protein-drug interactions in complex mixtures using protein stability measurements, Proc. Natl. Acad. Sci. Unit. States Am., 107, 9078, 10.1073/pnas.1000148107 · DOI · Paper page
  56. Geer, 2016, Characterization of the Saccharomyces cerevisiae ATP-Interactome using the iTRAQ-SPROX Technique, J. Am. Soc. Mass Spectrom., 27, 233, 10.1007/s13361-015-1290-z · DOI
  57. Liu, 2017, Large-scale Analysis of breast cancer-related conformational changes in proteins using SILAC-SPROX, J. Proteome Res., 16, 3277, 10.1021/acs.jproteome.7b00283 · DOI
  58. Walker, 2019, Global analysis of methionine oxidation provides a census of folding stabilities for the human proteome, Proc. Natl. Acad. Sci. Unit. States Am., 10.1073/pnas.1819851116 · DOI · Paper page
  59. Geer Wallace, 2016, Discovery of Manassantin a protein targets using large-scale protein folding and stability measurements, J. Proteome Res., 15, 2688, 10.1021/acs.jproteome.6b00237 · DOI
  60. Xu, 2016, Thermodynamic analysis of the geldanamycin–Hsp90 interaction in a whole cell lysate using a mass spectrometry-based proteomics approach, J. Am. Soc. Mass Spectrom., 27, 1670, 10.1007/s13361-016-1457-2 · DOI
  61. Ogburn, 2017, Discovery of tamoxifen and N-desmethyl tamoxifen protein targets in MCF-7 cells using large-scale protein folding and stability measurements, J. Proteome Res., 16, 4073, 10.1021/acs.jproteome.7b00442 · DOI
  62. Dearmond, 2011, Thermodynamic analysis of protein-ligand interactions in complex biological mixtures using a shotgun proteomics approach, J. Proteome Res., 10, 4948, 10.1021/pr200403c · DOI
  63. Meng, 2018, Proteome-wide characterization of phosphorylation-induced conformational changes in breast cancer, J. Proteome Res., 17, 1129, 10.1021/acs.jproteome.7b00795 · DOI
  64. Xu, 2011, Mass spectrometry- and lysine amidination-based protocol for thermodynamic analysis of protein folding and ligand binding interactions, Anal. Chem., 83, 3555, 10.1021/ac200211t · doi:10.1021/ac200211t
  65. Xu, 2014, Thermodynamic analysis of protein folding and stability using a tryptophan modification protocol, Anal. Chem., 86, 7041, 10.1021/ac501278j · DOI
  66. Ghaemmaghami, 2000, A quantitative, high-throughput screen for protein stability, Proc. Natl. Acad. Sci. U. S. A., 97, 8296, 10.1073/pnas.140111397 · DOI · Paper page
  67. Tucker, 2001, A yeast sensor of ligand binding, Nat. Biotechnol., 19, 1042, 10.1038/nbt1101-1042 · DOI
  68. Stankunas, 2003, Conditional protein alleles using knockin mice and a chemical inducer of dimerization, Mol. Cell, 12, 1615, 10.1016/S1097-2765(03)00491-X · DOI
  69. Pai, 2015, vol. 1263, 287
  70. Lomenick, 2009, Target identification using drug affinity responsive target stability (DARTS), Proc. Natl. Acad. Sci. U. S. A., 106, 21984, 10.1073/pnas.0910040106 · DOI · Paper page
  71. Pai, 2015, Drug affinity responsive target stability (DARTS) for small-molecule target identification, Methods Mol. Biol., 1263, 287, 10.1007/978-1-4939-2269-7_22 · DOI · Paper page
  72. Robinson, 2014, High-throughput screen identifies disulfiram as a potential therapeutic for triple-negative breast cancer cells: interaction with IQ motif-containing factors, Cell Cycle, 12, 3013, 10.4161/cc.26063 · DOI
  73. Lomenick, 2011, Identification of direct protein targets of small molecules, ACS Chem. Biol., 6, 34, 10.1021/cb100294v · DOI · Paper page
  74. Zeng, 2017, Discovery of nicotinamide adenine dinucleotide binding proteins in the Escherichia coli proteome using a combined energetic- and structural-bioinformatics-based approach, J. Proteome Res., 16, 470, 10.1021/acs.jproteome.6b00624 · DOI
  75. Adhikari, 2014, SILAC-pulse proteolysis: A mass spectrometry-based method for discovery and cross-validation in proteome-wide studies of ligand binding, J. Am. Soc. Mass Spectrom., 25, 2073, 10.1007/s13361-014-0992-y · DOI
  76. Fontana, 2004, Probing protein structure by limited proteolysis, Acta Biochim. Pol., 51, 299, 10.18388/abp.2004_3573 · DOI · Paper page
  77. Hubbard, 1998, The structural aspects of limited proteolysis of native proteins, Biochim. et Biophys. Acta Protein Struct. Mol. Enzymol., 1382, 191, 10.1016/S0167-4838(97)00175-1 · DOI · Paper page
  78. Schopper, 2017, Measuring protein structural changes on a proteome-wide scale using limited proteolysis-coupled mass spectrometry, Nat. Protoc., 12, 2391, 10.1038/nprot.2017.100 · DOI · Paper page
  79. Feng, 2014, Global analysis of protein structural changes in complex proteomes, Nat. Biotechnol., 32, 1036, 10.1038/nbt.2999 · DOI · Paper page
  80. Leuenberger, 2017, Cell-wide analysis of protein thermal unfolding reveals determinants of thermostability, Science, 355, 10.1126/science.aai7825 · DOI · Paper page
  81. Trapp, 1995, Ligand-induced conformational changes in the mineralocorticoid receptor analyzed by protease mapping, Biochem. Biophys. Res. Commun., 215, 286, 10.1006/bbrc.1995.2464 · DOI
  82. Huo, 1999, Ligand binding-dependent limited proteolysis of the atrial natriuretic peptide receptor: juxtamembrane hinge structure essential for transmembrane signal transduction, Biochemistry, 38, 16941, 10.1021/bi9919448 · DOI
  83. Dieckmann, 1999, Probing the domain structure and ligand-induced conformational changes by limited proteolysis of tyrocidine synthetase 1, J. Mol. Biol., 288, 129, 10.1006/jmbi.1999.2671 · doi:10.1006/jmbi.1999.2671
  84. Piazza, 2018, A map of protein-metabolite interactions reveals principles of chemical communication, Cell, 172, 358, 10.1016/j.cell.2017.12.006 · DOI · Paper page
  85. Kaur, 2018, Proteome-wide structural biology: an emerging field for the structural analysis of proteins on the proteomic scale, J. Proteome Res., 17, 3614, 10.1021/acs.jproteome.8b00341 · DOI
  86. Myers, 1995, Denaturant m values and heat capacity changes: relation to changes in accessible surface areas of protein unfolding, Protein Sci. Publ. Protein Soc., 4, 2138, 10.1002/pro.5560041020 · DOI · Paper page
  87. Dai, 2018, Modulation of protein-interaction states through the cell cycle, Cell, 173, 1481, 10.1016/j.cell.2018.03.065 · DOI · Paper page
  88. Strickland, 2014, False-positive rate determination of protein target discovery using a covalent modification- and mass spectrometry-based proteomics platform, J. Am. Soc. Mass Spectrom., 25, 132, 10.1007/s13361-013-0754-2 · DOI
  89. Meng, 2018, Chemical denaturation and protein precipitation approach for discovery and quantitation of protein–drug interactions, Anal. Chem., 90, 9249, 10.1021/acs.analchem.8b01772 · DOI
  90. Ma, 2018, Chemo-selection strategy for limited proteolysis experiments on the proteomic scale, Anal. Chem., 90, 14039, 10.1021/acs.analchem.8b04122 · DOI

Cited by

See all 42

Metadata

Authors
Lyu, J., Wang, K., & Ye, M.
Venue
TrAC Trends in Analytical Chemistry
Publisher
Elsevier BV
Published
2020-03
Volume
124
Pages
115574
ISSN
0165-9936
Cited by
42
References
9
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • National Key Research and Development Program of China (2016YFA0501402, 2017YFA0505003)
  • Dalian Institute of Chemical Physics (DICP&QIBEBT UN201802)
  • Ministry of Science and Technology of the People's Republic of China
  • Chinese Academy of Sciences
  • National Natural Science Foundation of China (81730016, 21535008, TMSR201601)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.